Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Go back to Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program| (NASDAQ: ASMB) | Delayed: 30.15 +0.35 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.80 | 52 Week High | $14.50 | |||
| Open | $30.31 | 52 Week Low | $4.33 | |||
| Day High | $30.48 | P/E | N/A | |||
| Day Low | $29.92 | EPS | $0.00 | |||
| Volume | 11,720 | |||||

